Exact Sciences Corp to Discuss Results of the Second-Generation Cologuard Study Call Transcript
Good day, and thank you for standing by. Welcome to the Cologuard 2.0 ASCO GI Data conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Megan Jones. Please go ahead.
Thank you, operator, and thank you for joining us to discuss results of the second-generation Cologuard study presented at ASCO GI this week. On the call today are Kevin Conroy, the company's Chairman and CEO; and Dr. John Kisiel, practicing gastroenterologist at Mayo Clinic and Exact Sciences collaborator; Scott Johnson, our Senior Vice President of Research and Development; and Jeff Elliott, our Chief Financial and Chief Operating Officer, will also be available for questions.
We'll only be taking questions on the results of the study today. Exact Sciences issued a news release yesterday afternoon detailing the study results. This news release and today's presentation are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |